Learn More
Medchemexpress LLC GSK 3008348 hydrochloride | 1629249-40-6 | 99.9% | 524.11 | 50 MG

Supplier: Medchemexpress LLC HY19767A50MG
GSK 3008348 hydrochloride is a small molecule antagonist of integrin αvβ6. It targets the αvβ6 integrin, inhibits TGF-β activation, and can alleviate the fibrotic process. It also prevents the binding of the foot-and-mouth disease virus (FMDV) to the αvβ6 integrin receptor, inhibiting virus entry. GSK 3008348 hydrochloride can be used for research on pulmonary fibrosis and various types of cancer.
- Small molecule antagonist of integrin αvβ6.
- Inhibits TGF-β activation.
- Alleviates the fibrotic process.
- Prevents binding of foot-and-mouth disease virus (FMDV) to the αvβ6 integrin receptor.
- Inhibits viral entry.
- Used for research on pulmonary fibrosis and various types of cancer.
- Antagonizes integrin αvβ6 with high affinity.
- Suppresses FMDV RNA replication and virus production.
- Decreases TGF-β1-activated procollagen I production.
- Inhibits TGF-β-induced phosphorylation of ERK1/2 and STAT3.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.